Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Glaucoma
Interventions: rhNGF, Vehicle; Drug
Lead sponsor: Dompé Farmaceutici S.p.A; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hypertension, Intracranial Hemorrhage, Subarachnoid Hemorrhage
Interventions: Clevidipine butyrate; Drug
Lead sponsor: Methodist Healthcare - Memphis; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: High Blood Pressure, Hypertension
Interventions: Audiotaped Counseling Session; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction, Group 2 Pulmonary Hypertension
Interventions: JK07; Drug
Lead sponsor: Salubris Biotherapeutics Inc; Industry
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Hyperlipidemia, Hypertension, Obesity
Interventions: Nutritional counseling, Walking program, Simple pedometer, Enhanced pedometer; Behavioral · Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hypertension
Interventions: Nebivolol; Drug
Lead sponsor: Mercy Research; Other
Eligibility: 18 Years to 90 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension, Systolic
Interventions: Zona Plus Device, Control Device; Device
Lead sponsor: Zona Health, Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: St Louis, Missouri • Charlotte, North Carolina • Goldsboro, North Carolina + 2 more

Conditions: Hypertension
Interventions: Remote patient monitoring for hypertension, Remote patient monitoring with care management; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 65 Years to 85 Years
Enrollment: 17,290 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cirrhosis, Liver, Portal Hypertension
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Ann Arbor, Michigan • Philadelphia, Pennsylvania • Dallas, Texas

Conditions: Cardiovascular Disease, Hypertension, Care Coordination, HIV Treatment Cascade
Interventions: Intervention group, Education control group; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: Decatur, Georgia • Baltimore, Maryland • Durham, North Carolina + 1 more

Conditions: Hypertension
Interventions: Magnetic field treatment; Device
Lead sponsor: Cardiovascular Therapy LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preeclampsia
Interventions: Not listed
Lead sponsor: Mike O'Callaghan Military Hospital; Federal
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Conditions: High Blood Pressure
Interventions: Telephone-based lifestyle counseling; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: New York, New York

Conditions: Hypertension
Interventions: Revision of congregate meal menus and recipes to align with parameters of DASH eating plan, On-site blood pressure monitoring, Home self blood pressure monitoring, Medical adherence education, Nutrition Education; Behavioral
Lead sponsor: Rockefeller University; Other
Eligibility: 60 Years to 105 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Hypertension, Metal Poison
Interventions: Metal level measurements; Diagnostic Test
Lead sponsor: Jiapeng Huang; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Intracerebral Hemorrhage, Stroke, Hypertension
Interventions: Clevidipine Injection, Alternate IV Antihypertensive Regimen; Drug
Lead sponsor: Zeenat Qureshi Stroke Institute; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,018 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 21
States / cities: Irvine, California • Lancaster, California • Palo Alto, California + 17 more

Conditions: Hypertension
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 470 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Portal Hypertension
Interventions: Particle, Coil; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 22 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Coronary Artery Disease, Hypertension, Dyslipidemia, Diabetes
Interventions: magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Treatment-Resistant Hypertension
Interventions: Structured center-based lifestyle intervention, Standard education and physician advice; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 35 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pre-eclampsia, Intrauterine Growth Retardation
Interventions: Modernized prenatal care; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 35 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, High Blood Pressure, African American Men
Interventions: Blood Pressure measurement and pharmacy; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 35 Years to 79 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pulmonary Arterial Hypertension
Interventions: Pemziviptadil (PB1046); Drug
Lead sponsor: PhaseBio Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 26
States / cities: Mobile, Alabama • Tucson, Arizona • La Jolla, California + 19 more

Conditions: Pulmonary Hypertension, Congenital Heart Disease, Pediatric Congenital Heart Disease
Interventions: cardiac catheterization, Cardiac MRI; Procedure · Radiation
Lead sponsor: University of Michigan; Other
Eligibility: 6 Years to 25 Years
Enrollment: 35 participants
Timeline: 2017 – 2023
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Columbus, Ohio

Search by objective public record fields.

Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy

Training in the 21st Century: Using Virtual Role-Plays to Improve Nurse Communication for Medication Adherence

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Veterans Walk for Health Study

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients

Hypertension Management Using Remote Patient Monitoring: Study 2

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study

A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention

Magneto-rheology to Lower Blood Pressure

Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia

Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients

DASH Diet Intervention at Senior Centers

Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

SPHERE Hypertension Baseline Data Study

Splenic Embolization for Portal Hypertension

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

Lifestyle Interventions in Treatment-Resistant Hypertension

A Modernized Approach to Prenatal Care in Low Risk Women

Cut Your Blood Pressure 3

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary Hypertension